Insider Transactions in Q1 2021 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 31
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Mar 31
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,089,000
$121.1 P/Share
|
Mar 31
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$605,000
$121.1 P/Share
|
Mar 31
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 31
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
4,888
-0.05%
|
$591,448
$121.07 P/Share
|
Mar 30
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$811,800
$123.3 P/Share
|
Mar 30
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
Mar 30
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
2,112,795
-2.89%
|
$253,535,400
$120.82 P/Share
|
Mar 29
2021
|
Afeyan Noubar |
SELL
Open market or private sale
|
Indirect |
1,635,122
-1.34%
|
$206,025,372
$126.98 P/Share
|
Mar 29
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$650,000
$130.05 P/Share
|
Mar 29
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.49%
|
$1,447,026
$131.85 P/Share
|
Mar 25
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$831,600
$126.88 P/Share
|
Mar 25
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
Mar 25
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,260,000
$126.88 P/Share
|
Mar 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Mar 24
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,233,000
$137.07 P/Share
|
Mar 24
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$685,000
$137.07 P/Share
|
Mar 24
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$685,000
$137.07 P/Share
|
Mar 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
Mar 23
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$957,000
$145.55 P/Share
|
Mar 23
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$132,000
$20.93 P/Share
|
Mar 23
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.1%
|
$2,115,000
$141.21 P/Share
|
Mar 23
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
Mar 22
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$720,000
$144.19 P/Share
|
Mar 22
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,199
-56.39%
|
$173,855
$145.26 P/Share
|
Mar 22
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,199
+50.0%
|
$23,980
$20.93 P/Share
|
Mar 19
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-1.87%
|
$1,568,532
$142.23 P/Share
|
Mar 18
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$950,400
$144.39 P/Share
|
Mar 18
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+24.75%
|
$151,800
$23.43 P/Share
|
Mar 18
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.13%
|
$1,440,000
$144.39 P/Share
|
Mar 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
Mar 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,341,000
$149.78 P/Share
|
Mar 17
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$745,000
$149.78 P/Share
|
Mar 17
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 16
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$976,800
$148.5 P/Share
|
Mar 16
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$165,000
$25.93 P/Share
|
Mar 15
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$685,000
$137.0 P/Share
|
Mar 15
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
Mar 15
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,034
-33.09%
|
$1,394,726
$139.66 P/Share
|
Mar 15
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,034
+25.17%
|
$170,578
$17.58 P/Share
|
Mar 15
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.92%
|
$2,055,000
$137.0 P/Share
|
Mar 15
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.46%
|
$75,000
$5.95 P/Share
|
Mar 12
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
5,000
-0.31%
|
$670,000
$134.04 P/Share
|
Mar 12
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+0.31%
|
$50,000
$10.9 P/Share
|
Mar 12
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-2.15%
|
$1,502,256
$136.09 P/Share
|
Mar 11
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$877,800
$133.29 P/Share
|
Mar 11
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$165,000
$25.93 P/Share
|